<p>Nutex Health Inc.（NASDAQ:NUTX - 獲取免費報告）的股票在週二的交易中達到了新的 52 周高點，此前一名內部人士購買了該公司的額外股份。該公司股票最高交易價為 137.32 美元，最後交易價為 129.67 美元，成交量為 212340 股。該股票此前收盤價為 132.03 美元。</p>
<p>具體來説，首席財務官 Jon Christian Bates 在 4 月 8 日（星期二）進行的一筆交易中購買了 1000 股該股票。每股購買價格為 81.81 美元，總交易額為 81,810.00 美元。收購後，首席財務官現在持有該公司 4888 股，價值 399,887.28 美元。此次交易使其持股增加了 25.72%。該收購已在向 SEC 提交的法律文件中披露，文件可通過此鏈接獲取。</p>
<h2>華爾街分析師觀點</h2>
<p>另外，Maxim Group 在 4 月 8 日的研究報告中將 Nutex Health 的目標股價從 75.00 美元上調至 100.00 美元，並給予該股票 “買入” 評級。</p>
<p><strong>查看我們最新的 Nutex Health 股票報告</strong></p>
<h2>Nutex Health 價格表現</h2>
<p>該公司的 50 日移動平均線為 64.12 美元，200 日移動平均線為 42.85 美元。公司的流動比率為 1.77，速動比率為 1.74，債務與股本比率為 3.36。公司的市值為 7.1682 億美元，市盈率為-13.81，貝塔值為 0.27。</p>
<p>Nutex Health（NASDAQ:NUTX - 獲取免費報告）最近於 3 月 31 日（星期一）公佈了季度財報。該公司報告每股收益為 11.12 美元，超出市場共識預期的（0.09 美元）11.21 美元。Nutex Health 的股本回報率為-51.27%，淨利潤率為-14.09%。該公司在本季度的收入為 8130 萬美元，而市場共識預期為 8113 萬美元。</p>
<h2>機構投資者對 Nutex Health 的看法</h2>
<p>大型投資者最近增加或減少了對該公司的持股。Topline Capital Management LLC 在第四季度購買了 Nutex Health 的新股份，價值約 569 萬美元。American Century Companies Inc.在第四季度購買了 Nutex Health 的新頭寸，價值約 136.2 萬美元。Ancora Advisors LLC 在第四季度購買了 Nutex Health 的新股份，價值約 133.4 萬美元。Drive Wealth Management LLC 在第四季度購買了 Nutex Health 的新股份，價值約 112.2 萬美元。最後，Essex Investment Management Co. LLC 在第四季度將其在 Nutex Health 的持股增加了 45.4%。Essex Investment Management Co. LLC 目前持有該公司 105,809 股股票，價值 335.3 萬美元，此前在上個季度又購買了 33,024 股。機構投資者持有該公司 5.32% 的股份。</p>
<h2>關於 Nutex Health</h2>
<p>（獲取免費報告）</p>
<p>Nutex Health Inc 是一家由醫生主導的醫療服務和運營公司。它通過三個部門運營：醫院、人口健康管理（PHM）和房地產。PHM 部門建立和運營獨立的醫生協會；併為醫療組織提供基於雲的平台，以提供基於價值的護理和人口健康管理。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票比 Nutex Health 更好</li>
<li>賣空 - 利弊分析</li>
<li>為什麼 NVIDIA 股票可能會在華爾街下調評級後飆升</li>
<li>3 只天然氣股票提供優厚的股息收益</li>
<li>第一季度內部人士購買的三隻大型股：買入、賣出還是持有</li>
<li>交易暫停解釋</li>
<li>3 只熱新 IPO 逆勢而上，抵禦 2025 年市場下滑</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Nutex Health 嗎？</h2>
<p>在考慮 Nutex Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買...而 Nutex Health 並不在名單上。</p>
<p>雖然 Nutex Health 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

NUTX

<p>Nutex Health（納斯達克代碼：NUTX）在首席財務官 Jon Christian Bates 的內部購買後，達到了新的 52 周高點 137.32 美元，他以每股 81.81 美元購買了 1,000 股。該股票最後交易於 129.67 美元。Maxim Group 將其目標價從 75 美元上調至 100 美元，維持 “買入” 評級。Nutex 報告每股收益為 11.12 美元，超出預期，收入為 8130 萬美元。機構投資者持有該公司 5.32% 的股份，該公司在醫療服務領域運營，分為三個部門：醫院、人口健康管理和房地產</p>

<p>Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) reached a new 52-week high during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $137.32 and last traded at $129.67, with a volume of 212340 shares. The stock had previously closed at $132.03.</p>
<div class="lb-trans"><p>Nutex Health Inc.（NASDAQ:NUTX - 獲取免費報告）的股票在週二的交易中達到了新的 52 周高點，此前一名內部人士購買了該公司的額外股份。該公司股票最高交易價為 137.32 美元，最後交易價為 129.67 美元，成交量為 212340 股。該股票此前收盤價為 132.03 美元。</p>
</div><p>Specifically, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>具體來説，首席財務官 Jon Christian Bates 在 4 月 8 日（星期二）進行的一筆交易中購買了 1000 股該股票。每股購買價格為 81.81 美元，總交易額為 81,810.00 美元。收購後，首席財務官現在持有該公司 4888 股，價值 399,887.28 美元。此次交易使其持股增加了 25.72%。該收購已在向 SEC 提交的法律文件中披露，文件可通過此鏈接獲取。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Separately, Maxim Group lifted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a &#34;buy&#34; rating in a research report on Tuesday, April 8th.</p>
<div class="lb-trans"><p>另外，Maxim Group 在 4 月 8 日的研究報告中將 Nutex Health 的目標股價從 75.00 美元上調至 100.00 美元，並給予該股票 “買入” 評級。</p>
</div><p><strong>View Our Latest Stock Report on Nutex Health</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 Nutex Health 股票報告</strong></p>
</div><h2>Nutex Health Price Performance</h2>
<div class="lb-trans"><h2>Nutex Health 價格表現</h2>
</div><p>The firm has a fifty day moving average of $64.12 and a two-hundred day moving average of $42.85. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The company has a market capitalization of $716.82 million, a PE ratio of -13.81 and a beta of 0.27.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均線為 64.12 美元，200 日移動平均線為 42.85 美元。公司的流動比率為 1.77，速動比率為 1.74，債務與股本比率為 3.36。公司的市值為 7.1682 億美元，市盈率為-13.81，貝塔值為 0.27。</p>
</div><p>Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.</p>
<div class="lb-trans"><p>Nutex Health（NASDAQ:NUTX - 獲取免費報告）最近於 3 月 31 日（星期一）公佈了季度財報。該公司報告每股收益為 11.12 美元，超出市場共識預期的（0.09 美元）11.21 美元。Nutex Health 的股本回報率為-51.27%，淨利潤率為-14.09%。該公司在本季度的收入為 8130 萬美元，而市場共識預期為 8113 萬美元。</p>
</div><h2>Institutional Investors Weigh In On Nutex Health</h2>
<div class="lb-trans"><h2>機構投資者對 Nutex Health 的看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. Topline Capital Management LLC purchased a new stake in shares of Nutex Health during the fourth quarter worth about $5,690,000. American Century Companies Inc. bought a new position in Nutex Health during the 4th quarter valued at approximately $1,362,000. Ancora Advisors LLC purchased a new stake in Nutex Health in the 4th quarter worth approximately $1,334,000. Drive Wealth Management LLC purchased a new stake in Nutex Health in the 4th quarter worth approximately $1,122,000. Finally, Essex Investment Management Co. LLC grew its position in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors own 5.32% of the company's stock.</p>
<div class="lb-trans"><p>大型投資者最近增加或減少了對該公司的持股。Topline Capital Management LLC 在第四季度購買了 Nutex Health 的新股份，價值約 569 萬美元。American Century Companies Inc.在第四季度購買了 Nutex Health 的新頭寸，價值約 136.2 萬美元。Ancora Advisors LLC 在第四季度購買了 Nutex Health 的新股份，價值約 133.4 萬美元。Drive Wealth Management LLC 在第四季度購買了 Nutex Health 的新股份，價值約 112.2 萬美元。最後，Essex Investment Management Co. LLC 在第四季度將其在 Nutex Health 的持股增加了 45.4%。Essex Investment Management Co. LLC 目前持有該公司 105,809 股股票，價值 335.3 萬美元，此前在上個季度又購買了 33,024 股。機構投資者持有該公司 5.32% 的股份。</p>
</div><h2>About Nutex Health</h2>
<div class="lb-trans"><h2>關於 Nutex Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.</p>
<div class="lb-trans"><p>Nutex Health Inc 是一家由醫生主導的醫療服務和運營公司。它通過三個部門運營：醫院、人口健康管理（PHM）和房地產。PHM 部門建立和運營獨立的醫生協會；併為醫療組織提供基於雲的平台，以提供基於價值的護理和人口健康管理。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Nutex Health</li>
<li>Short Selling - The Pros and Cons</li>
<li>Why NVIDIA Stock Could Soar Despite Wall Street Downgrades</li>
<li>3 Natural Gas Stocks That Offer Great Dividend Yields</li>
<li>Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold</li>
<li>Trading Halts Explained</li>
<li>3 Hot New IPOs Defying the 2025 Market Slump</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Nutex Health 更好</li>
<li>賣空 - 利弊分析</li>
<li>為什麼 NVIDIA 股票可能會在華爾街下調評級後飆升</li>
<li>3 只天然氣股票提供優厚的股息收益</li>
<li>第一季度內部人士購買的三隻大型股：買入、賣出還是持有</li>
<li>交易暫停解釋</li>
<li>3 只熱新 IPO 逆勢而上，抵禦 2025 年市場下滑</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Nutex Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Nutex Health 嗎？</h2>
</div><p>Before you consider Nutex Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Nutex Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買...而 Nutex Health 並不在名單上。</p>
</div><p>While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Nutex Health 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Nutex Health（NASDAQ:NUTX）在內部人士買入活動後創下新的一年高點